ABT vs TCNNF · P/E 25, rev $44.33B vs rev $1.19B
Abbott Laboratories (ABT) versus Trulieve Cannabis Corp (TCNNF) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Trulieve Cannabis Corp (TCNNF) common stock listed on OTCQX.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported TCNNF revenue for 2024-12-31 was $1.19B. Net income was -$160.6M. Revenue was up 5.1% from 2023-12-31 to 2024-12-31. TCNNF currently screens at market cap $1.82B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. TCNNF currently screens at market cap $1.82B.
Not investment advice. Open the ABT and TCNNF stock pages for the full models.
Not investment advice.